Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

View:
Post by LegallyBlonde on Jul 24, 2020 2:23pm

Thanks

By the way thanks for the tip on MIST pinkfloyd and Jericho... I think, didn’t hit it huge like you guys but bought in 8.04 sold 10.61, so I’m happy!!
Comment by pinkfloyd90 on Jul 24, 2020 2:39pm
actually it was jerico...I bought on his recommendation....made very good money...at least you made some too....
Comment by pinkfloyd90 on Jul 24, 2020 2:55pm
Legallyblonde...jerico also recommended GSTR as you are aware and I am into that one as well...that's a winner too...but I am holding onto rvv for the long run....look how fast and how much MIST moves...like "night moves" by Bob Segar.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities